Antimicrobial Susceptibility Testing Market Poised to Reach New Heights as Infections Rise
The antimicrobial susceptibility testing market is projected to reach USD 4.7 Billion in 2027 from 3.6 Billion in 2022 at a CAGR of 5.5% during the forecast period. The high prevalence of infectious diseases, rising government funding and initiatives for antimicrobial susceptibility testing programs, technological developments for the creation of new AST methods, and the emergence of multidrug resistance in microorganisms are the main factors driving the antimicrobial susceptibility testing market. However, strict government controls are anticipated to limit this market's expansion to some degree. Players in the antimicrobial susceptibility testing market may anticipate having tremendous growth potential as a result of emerging markets and ongoing R&D to provide quick antimicrobial susceptibility testing. The Antimicrobial susceptibility testing market is moderately competitive, with both established companies and upcoming competitors for the same market share. A...